Dart Drug management
Chairman Alvin Towle has resigned from the company "to pursue other interests," selling his holding in the 77-store drug chain, Dart announced Jan. 28. A veteran exec of the three major Wash., D.C. area chains -- Dart, Peoples and Drug Fair -- Towle was a principal in the $160 mil. purchase of Dart via a leverage buyout in 1984. He headed the drugstore operation until last October, when he shifted his efforts into the strategic planning area. Stephen Hansbrough, who together with Towle has been managing Dart Drug since it went private, has assumed Towle's position as chairman.
You may also be interested in...
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.